Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dechra Pharmaceuticals PLC (DE:1PK)
FRANKFURT:1PK
RESEARCH TOOLSreports
Dechra Pharmaceuticals (1PK) Stock Forecast & Price Target
3 Followers
See the Price Targets and Ratings of:
1PK Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1PK Stock 12 Month Forecast
There Are No Analyst Ratings for DE:1PK In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
1PK Financial Forecast
Detailed List of Analyst Forecasts
Stifel Nicolaus
€45.13
Hold
1.63%
Upside
Downgraded
06/27/23
Stifel Downgrades Dechra Pharma (DPH:LN) (DCHPF) to HoldStifel analyst Max Herrmann downgraded Dechra Pharma (DPH:LN) (OTC: DCHPF) from Buy to Hold with a price target of GBP38.75 (from GBP40.00).
Exane BNP Paribas
€47.40
Buy
6.75%
Upside
Upgraded
05/25/23
Exane BNP Paribas Upgrades Dechra Pharma (DPH:LN) (DCHPF) to OutperformExane BNP Paribas analyst Laurent Gelebart upgraded Dechra Pharma (DPH:LN) (OTC: DCHPF) from Neutral to Outperform with a price target of GBP40.70.
J.P. Morgan
€46.80
Buy
5.41%
Upside
Reiterated
03/07/23
Dechra Pharma (DPH:LN) (DCHPF) PT Lowered to GBP40 at JPMorganJPMorgan analyst James Gordon lowered the price target on Dechra Pharma (DPH:LN) (OTC: DCHPF) to GBP40.00 (from GBP46.00) while maintaining a Overweight rating.
Jefferies
€36.41
Buy
-17.99%
Downside
Reiterated
02/28/23
Dechra Pharma (DPH:LN) (DCHPF) PT Raised to GBP31.24 at JefferiesJefferies analyst James Vane-Tempest raised the price target on Dechra Pharma (DPH:LN) (OTC: DCHPF) to GBP31.24 (from GBP31.12) while maintaining a Buy rating.
Unknown Analyst
Not Ranked
Numis
€46.80
Buy
5.41%
Upside
Reiterated
05/22/23
Unknown Analyst
Not Ranked
Deutsche Bank
€47.62
Buy
7.25%
Upside
Reiterated
05/25/23
Best Analysts Covering Dechra Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy DE:1PK and Sell After:
1 Month
3 Months
1 Year
Success Rate
7/9 ratings generated profit
Average Return
+7.91%
reiterated a buy rating a year ago
Copying Anand Date's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +7.91% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1PK Analyst Recommendation Trends
Rating
Jan 23
Feb 23
Mar 23
May 23
Jun 23
Strong Buy
3
2
2
0
0
Buy
2
2
4
7
5
Hold
2
3
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
7
8
6
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
1PK Stock Forecast FAQ
What is DE:1PK’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:1PK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:1PK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dechra Pharmaceuticals PLC a Buy, Sell or Hold?
Currently, no data Available
What is Dechra Pharmaceuticals PLC’s share price target?
Currently, no data Available
What do analysts say about Dechra Pharmaceuticals PLC?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Dechra Pharmaceuticals PLC?
To buy shares of DE:1PK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.